Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) and UF Innovate client Alchem Laboratories Corporation (Alchem) announced the formation of a strategic alliance to develop essential medicine therapeutics, improving supply chain resiliency.
Cost Plus Drugs is employing a highly automated and flexible manufacturing platform that integrates AI and machine learning for real-time quality assessment and process optimization to produce lidocaine, a widely used anesthetic, and diltiazem, a calcium channel blocker used to treat heart conditions., Alchem provided process development of these APIs for Cost Plus Drugs.
Read more about Mark Cuban Cost Plus Drugs and Alchem Laboratories Announce Alliance To Advance Essential Medicines.
